EUR vs Mali: Hepatitis B surface antigen (HBsAg) prevalence (%)
EUR
0.1%
in 2024
Mali
1.8%
in 2024
EUR rank
10th
Mali rank
13th
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- EUR
- Mali
How they compare
Mali currently reports 1.8% against 0.1% in EUR, a difference of 1.7%.
That makes Mali's figure about 18.0 times EUR's.
Across all 10 years both countries report, Mali has been ahead every year.
EUR ranks 10th and Mali ranks 13th of 13 groups.
Mali has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | EUR | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 2.1% | 2.0% | Mali |
| 2020s | 0.1% | 2.1% | 2.0% | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, EUR or Mali?
- Mali, at 1.8% against 0.1% in EUR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between EUR and Mali?
- 1.7%, with Mali ahead.
- How many years of comparable data are there for EUR and Mali?
- 10 years are reported by both, from 2015 to 2024.
- How do EUR and Mali rank globally for hepatitis b surface antigen (hbsag) prevalence?
- EUR ranks 10th and Mali ranks 13th of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.